Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | CA9 | Q16790 | 2/20 | 0.52 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | MMP3 | P08254 | 1/20 | 0.39 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 8/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | BAX | Q07812 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL2382227 | 0.92 | CA12 (0.44) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL1997779 | 0.90 | CA12 (0.65) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL5491910 | 0.87 | CA12 (0.61) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL27329051 | 0.84 | CA12 (0.73) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL42361 | 0.84 | CA12 (0.73) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL28084399 | 0.84 | CA12 (0.73) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL28215094 | 0.84 | CA12 (0.73) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL8718742 | 0.84 | CA12 (0.73) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL28042326 | 0.82 | CA12 (0.69) | CA12CA2CA9CA14CA1 | |
| Phenol SCHEMBL546282 | 0.81 | CA12 (0.52) | CA12CA2CA9CA14CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113481294-B | Method for preparing nucleic acid sample | 花王株式会社 | 2024-03-12 | — | — | CN | disclosed |
| CN-110249048-A | For extracting the universal method of nucleic acid molecules from one of sample or the diverse populations of a plurality of types of microorganisms | 太阳基因组学公司 | 2019-09-17 | — | — | CN | disclosed |
| EP-2295065-B1 | Modified heat shock protein-antigenic peptide complex | UNIV MIAMI (US) | 2013-10-09 | — | — | EP | disclosed |
| US-8435534-B2 | Cancer immunotherapy | THE PENN STATE RESEARCH FOUNDATION (US) | 2013-05-07 | — | — | US | disclosed |
| US-20120083009-A1 | Rheumatoid Arthritis Test Method And Treating Method | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2012-04-05 | — | — | US | disclosed |
| US-20110280885-A1 | CANCER IMMUNOTHERAPY | THE PENN STATE RESEARCH FOUNDATION (US) | 2011-11-17 | — | — | US | disclosed |
| US-20110110955-A1 | ANTIBODY CANCER IMMUNOTHERAPY | THE PENN STATE RESEARCH FOUNDATION (US) | 2011-05-12 | — | — | US | disclosed |
| EP-2295065-A1 | Modified heat shock protein-antigenic peptide complex | The University of Miami (US) | 2011-03-16 | — | — | EP | disclosed |
| EP-1829551-B1 | Modified heat shock protein-antigenic peptide complex | UNIV MIAMI (US) | 2010-09-29 | — | — | EP | disclosed |
| US-20090176245-A1 | Rheumatoid Arthritis Test Method and Treating Method | NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY (JP) | 2009-07-09 | — | — | US | disclosed |
| WO-2002064097-A2 | VEGF-D EXPRESSION IN BRAIN CANCER | THE PENN STATE RESEARCH FOUNDATION (US) | 2002-08-22 | — | — | WO | disclosed |
| WO-2002064023-A2 | FRA-1 EXPRESSION IN BRAIN CANCER | THE PENN STATE RESEARCH FOUNDATION (US) | 2002-08-22 | — | — | WO | disclosed |
| EP-1151132-A2 | METHODS AND REAGENTS FOR INACTIVATING RIBONUCLEASES | AMBION, INC. (US) | 2001-11-07 | — | — | EP | disclosed |
| WO-2001058479-A1 | IMMUNOTHERAPY USING INTERLEUKIN 13 RECEPTOR SUBUNIT ALPHA 2 | THE PENN STATE RESEARCH FOUNDATION (US) | 2001-08-16 | — | — | WO | disclosed |
| EP-1064017-A1 | A METHOD FOR THE PREVENTION OF A PATIENT'S FIBROPROLIFERATIVE VASCULOPATHY | Oy Juvantia Pharma Ltd (FI) | 2001-01-03 | — | — | EP | disclosed |
| EP-1054683-A1 | MODIFIED HEAT SHOCK PROTEIN-ANTIGENIC PEPTIDE COMPLEX | UNIVERSITY OF MIAMI (US) | 2000-11-29 | — | — | EP | disclosed |
| US-6124256-A | ADMINISTERING AN AGONIST SPECIFIC FOR SOMATOSTATIN (SST) RECEPTOR(S) SHOWING AN INCREASED EXPRESSION IN THE VASCULAR WALL SUBSEQUENT TO INJURY OR SURGERY | OY JUVANTIA PHARMA LTD. (FI) | 2000-09-26 | — | — | US | disclosed |
| WO-2000017320-A2 | METHODS AND REAGENTS FOR INACTIVATING RIBONUCLEASES | AMBION, INC. (US) | 2000-03-30 | — | — | WO | disclosed |
| WO-1999049884-A1 | A METHOD FOR THE PREVENTION OF A PATIENT'S FIBROPROLIFERATIVE VASCULOPATHY | OY JUVANTIA PHARMA LTD. (FI) | 1999-10-07 | — | — | WO | disclosed |
| WO-1999042121-A1 | MODIFIED HEAT SHOCK PROTEIN-ANTIGENIC PEPTIDE COMPLEX | UNIVERSITY OF MIAMI (US) | 1999-08-26 | — | — | WO | disclosed |